Cite
HARVARD Citation
Pellicori, P. et al. (2020). Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European journal of heart failure. pp. 1711-1723. [Online].